Drug Control
-
{
- All
- News
- Videos
-
Real Or Fake Paneer? All Gujarat Restaurants Ordered To Say It On Menu
The Gujarat FDCA has issued a statewide warning against the use of "analogue" products being passed off as paneer.
-
Public Health Alert: Rajasthan Bans 7 Sub-Standard Medicines
Jaipur, April 22 (IANS) Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality” following laboratory test
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
Licenses of 18 pharma companies have been cancelled and they have been asked to stop manufacturing, sources in the Union Health ministry have told NDTV. Show cause notices have been issued to 26 pharma companies, sources said.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Maharashtra Drug Body Asks States To Stop Jab For Anaemia As Patient Dies
The Maharashtra Food & Drug Administration (FDA) has asked all drug controller authorities in the country to stop the use of a particular batch of drug INJ OROFER FCM following the death of a patient at a Mumbai hospital.
-
"Test Solvents": Karnataka Tells Drugmakers After WHO Cough Syrup Alert
Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
Real Or Fake Paneer? All Gujarat Restaurants Ordered To Say It On Menu
The Gujarat FDCA has issued a statewide warning against the use of "analogue" products being passed off as paneer.
-
Public Health Alert: Rajasthan Bans 7 Sub-Standard Medicines
Jaipur, April 22 (IANS) Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality” following laboratory test
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
18 Pharma Companies To Lose Licenses Over Poor Quality Medicines: Sources
Licenses of 18 pharma companies have been cancelled and they have been asked to stop manufacturing, sources in the Union Health ministry have told NDTV. Show cause notices have been issued to 26 pharma companies, sources said.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
Maharashtra Drug Body Asks States To Stop Jab For Anaemia As Patient Dies
The Maharashtra Food & Drug Administration (FDA) has asked all drug controller authorities in the country to stop the use of a particular batch of drug INJ OROFER FCM following the death of a patient at a Mumbai hospital.
-
"Test Solvents": Karnataka Tells Drugmakers After WHO Cough Syrup Alert
Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
